Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Skin Pharmacology and Physiology is Scopus-indexed (Q1, CiteScore 7), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1660-5527Verify ISSN ↗1660-5535Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Dermatology | 10 / 152 | 93rd | Q1 |
| Physiology | 46 / 196 | 76th | Q1 |
| Pharmacology | 79 / 328 | 76th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present (also 1988–1997), best quartile Q1, CiteScore 7.
Skin Pharmacology and Physiology is Q1 in Dermatology (rank 10 of 152), Q1 in Physiology (rank 46 of 196) and Q1 in Pharmacology (rank 79 of 328), by CiteScore 2025.
Skin Pharmacology and Physiology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.977, quartile Q1, with an H-index of 91.
Skin Pharmacology and Physiology is published by S. Karger AG. Its print ISSN is 1660-5527 and its online ISSN is 1660-5535.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Skin Pharmacology and Physiology has an h-index of 99 and a 2-year mean of 1 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q1. On 2-year citations it ranks #75 of 144 Scopus journals in Dermatology.
Skin Pharmacology and Physiology published 30 papers in 2025; its busiest recent year was 2021 with 57. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2023–2026), authors are most often from Germany (22%), China (16.7%) and United States (14.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.